Belief BioMed Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 270

Employees

  • Latest Deal Type
  • Series C

  • Latest Deal Amount
  • $120M

  • Investors
  • 7

Belief BioMed General Information

Description

Developer of gene therapy drugs designed for rare genetic and chronic diseases. The company's technology utilizes engineered aav capsids with tissue targeting and low immunogenicity, providing patients with treatment options for rare genetic and chronic conditions.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Block K, 5th Floor
  • Number 780 Cailun Road, China Pilot Free Trade Zone
  • Shanghai
  • China
+86 021
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Block K, 5th Floor
  • Number 780 Cailun Road, China Pilot Free Trade Zone
  • Shanghai
  • China
+86 021

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Belief BioMed Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series C) 01-Mar-2022 $120M Completed Generating Revenue
5. Early Stage VC 01-Aug-2021 Completed Generating Revenue
4. Early Stage VC (Series B) 01-Dec-2020 Completed Generating Revenue
3. Secondary Transaction - Private 28-May-2020 Completed Generating Revenue
2. Early Stage VC (Series A) 21-Apr-2020 $40M $50.9M Completed Generating Revenue
1. Seed Round 19-Jun-2018 $10.9M $10.9M Completed Startup
To view Belief BioMed’s complete valuation and funding history, request access »

Belief BioMed Patents

Belief BioMed Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2022222869-A1 Recombinant adeno-associated virus and application thereof Inactive 19-Apr-2021
AU-2020258972-A1 A new type of enzyme composition Active 19-Apr-2019
AU-2020258972-B2 A new type of enzyme composition Active 19-Apr-2019
CA-3136853-A1 A new type of enzyme composition Pending 19-Apr-2019
EP-3956440-A1 A new type of enzyme composition Pending 19-Apr-2019 C12N9/0071
To view Belief BioMed’s complete patent history, request access »

Belief BioMed Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Belief BioMed Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
CDG Capital Growth/Expansion Minority
LAV (Lilly Asia Fund) Corporate Venture Capital Minority
MPC (Beijing) Venture Capital Minority
Cenova Capital Venture Capital Minority
Qiming Venture Partners Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

Belief BioMed FAQs

  • When was Belief BioMed founded?

    Belief BioMed was founded in 2018.

  • Where is Belief BioMed headquartered?

    Belief BioMed is headquartered in Shanghai, China.

  • What is the size of Belief BioMed?

    Belief BioMed has 270 total employees.

  • What industry is Belief BioMed in?

    Belief BioMed’s primary industry is Drug Discovery.

  • Is Belief BioMed a private or public company?

    Belief BioMed is a Private company.

  • What is the current valuation of Belief BioMed?

    The current valuation of Belief BioMed is .

  • What is Belief BioMed’s current revenue?

    The current revenue for Belief BioMed is .

  • How much funding has Belief BioMed raised over time?

    Belief BioMed has raised $271M.

  • Who are Belief BioMed’s investors?

    CDG Capital, LAV (Lilly Asia Fund), MPC (Beijing), Cenova Capital, and Qiming Venture Partners are 5 of 7 investors who have invested in Belief BioMed.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process